Skip to main content

Advertisement

Log in

Vascular endothelial growth factor and endoglin expression in colorectal cancer

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose and methods

Vascular endothelial growth factor (VEGF) overexpression has been associated with advanced stage and poor survival in several cancers. Additionally, endoglin was proposed as a marker of neovascularization in solid malignancies. The aim of this study was to evaluate the association between the VEGF and endoglin expression in colorectal carcinoma patients, as well as to correlate the VEGF and endoglin expression with standard parameters, to define their potential prognostic role. VEGF and endoglin expression were evaluated in 99 unrelated patients with colorectal cancer using immunohistochemistry.

Results

Vascular endothelial growth factor and endoglobin expression were positively interrelated. No significant correlation of VEGF and endoglin expression with clinicopathological parameters was observed in our cases. The Kaplan–Meier survival curves have demonstrated a clear association of cancer-specific overall survival with high VEGF, as well as high endoglin expression.

Conclusion

Our results support that VEGF and endoglin act as two valuable indicators of prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Bossi P, Viale G, Lee AK, Alfano R, Coggi G, Bosari S (1995) Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 55:5049–5053

    CAS  PubMed  Google Scholar 

  • Chung YS, Maeda K, Sowa M (1996) Prognostic value of angiogenesis in gastrointestinal tumors. Eur J Cancer 32A:2501–2505

    Article  CAS  PubMed  Google Scholar 

  • Couvelard A, Paraf F, Gratio V, Scoazec JY, Hénin D, Degott C, Fléjou JF (2000) Angiogenesis in the neoplastic sequence of Barrett’s esophagus: correlation with VEGF expression. J Pathol 192:14–18

    Article  CAS  PubMed  Google Scholar 

  • Du JR, Jiang Y, Zhang YM, Fu Y (2003) Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinoma. World J Gastroenterol 9:1604–1606

    CAS  PubMed  Google Scholar 

  • Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J17:984–992

    Article  Google Scholar 

  • Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795–803

    Article  CAS  PubMed  Google Scholar 

  • Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6

    Article  CAS  PubMed  Google Scholar 

  • Fondevila C, Metges JP, Fuster J, Grau JJ, Palacín A, Castells A, Volant A, Pera M (2004) p53 and VEGF expression are independent predictors of tumor recurrence and survival following curative resection of gastric cancer. Br J Cancer 90:206–215

    Article  CAS  PubMed  Google Scholar 

  • Frank RE, Saclarides TJ, Leurgans S, Speziale NJ, Drab EA, Rubin DB (1995) Tumor angiogenesis as predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 222:695–699

    Article  CAS  PubMed  Google Scholar 

  • Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Försti A (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647–3653

    Article  CAS  PubMed  Google Scholar 

  • Kang SM, Maeda K, Onoda N (1997) Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 74:502–507

    Article  CAS  PubMed  Google Scholar 

  • Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G, Tahara E (1998) Significance of vessel count and vascular endothelial growth factor in human esophageal carcinoma. Clin Cancer Res 4:2195–2200

    CAS  PubMed  Google Scholar 

  • Lee JC, Chow NH, Wang ST, Huang SM (2000) Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36:748–753

    Article  CAS  PubMed  Google Scholar 

  • Los M, Roodhart JML, Voist EE (2007) Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist 12:443–450

    Article  CAS  PubMed  Google Scholar 

  • Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O (2006) Enoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 448:127–134

    Article  CAS  PubMed  Google Scholar 

  • Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9–22

    CAS  PubMed  Google Scholar 

  • Nikiteas N, Tzanakis N, Theodoropoulos G, Atsaves V, Christoni Z, Karakitsos P, Lazaris AC, Papachristodoulou A, Klonaris C, Gazouli M (2007) Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer 10:12–17

    Article  CAS  PubMed  Google Scholar 

  • Pietra N, Sarli L, Caruana P, Cabras A, Costi R, Gobbi S, Bordi C, Peracchia A (2000) Is tumor angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes? Eur J Surg 166:552–556

    Article  CAS  PubMed  Google Scholar 

  • Polverini PJ, Leibovich SJ (1984) Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51:635–642

    CAS  PubMed  Google Scholar 

  • Saad RS, Jasnosz KM, Silverman JF (2003) Endoglin (CD105) expression in endometrial carcinoma. Int J Gynecol Pathol 22:248–253

    Article  PubMed  Google Scholar 

  • Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF (2004) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 17:197–203

    Article  CAS  PubMed  Google Scholar 

  • Saclarides TJ, Speziale NJ, Drab E, Szeluga DJ, Rubin DB (1994) Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 37:921–926

    Article  CAS  PubMed  Google Scholar 

  • Scon BK, Matsuno F, Haruta Y, Kondo M, Barcos M (1997) Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res 3:1031–1044

    Google Scholar 

  • Takahashi Y, Tucker SL, Kitadai Y (1997) Vessel counts and expression of vascular endothelial growth factors as prognostic factors in node-negative colon cancer. Arch Surg 132:541–546

    CAS  PubMed  Google Scholar 

  • Wang JM, Kumar S, Pye D, Haboubi N, al-Nakib L (1994) Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst 86:386–388

    Article  CAS  PubMed  Google Scholar 

  • Weidner N (1995) Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147:9–19

    CAS  PubMed  Google Scholar 

  • Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324:1–8

    Article  CAS  PubMed  Google Scholar 

  • Wilkstrom P, Lissbrant IF, Stattin P, Egevad L, Bergh A (2002) Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51:268–275

    Article  CAS  Google Scholar 

  • Yamamori M, Sakaeda T, Nakamura T, Okamura N, Tamura T, Aoyama N, Kamigaki T, Ohno M, Shirakawa T, Gotoh A, Kuroda Y, Matsuo M, Kasuga M, Okumura K (2004) Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochem Biophys Res Commun 325:144–150

    Article  CAS  PubMed  Google Scholar 

  • Yu JX, Zhang XT, Liao YQ, Zhang QY, Chen H, Lin M, Kumar S (2003) Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance. World J Gastroenterol 9:2866–2869

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The project was co-funded by the European Social Fund and National Resources, (EPEAEKII) PYTHAGORAS.

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Gazouli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dassoulas, K., Gazouli, M., Theodoropoulos, G. et al. Vascular endothelial growth factor and endoglin expression in colorectal cancer. J Cancer Res Clin Oncol 136, 703–708 (2010). https://doi.org/10.1007/s00432-009-0709-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-009-0709-y

Keywords

Navigation